The Drug Development Journey for New Cancer Treatments - Part 2

Explore the second part of a 17-minute webinar presented by Professor Nick Turner, a renowned expert in breast cancer research and treatment. Delve into clinical studies on AKT inhibitors as part of the drug development journey for new cancer treatments. Gain insights from Turner's role as Team Leader at the Breast Cancer Now Toby Robins Research Centre and his experience as a Consultant Medical Oncologist at the Royal Marsden Hospital. Learn about cutting-edge research in cancer drug development and its potential impact on patient care. For a comprehensive understanding, view the first part of this presentation available through the provided link. Discover more about this research and related topics by visiting the official website of the Academic Health Science Centre.

The drug development journey for new cancer treatments – Prof. Nick Turner (Part 2 of 2)